Knight Therapeutics Inc. (GUD.TO) is scheduled to present a corporate update at the Bloom Burton & Co. Healthcare Investor Conference on Tuesday, April 16, 2024.
This pan-American specialty pharmaceutical company is focused on acquiring or in-licensing and commercializing pharmaceutical products for Canada and Latin America.
For the year ended Dec.31, 2023, the results of which were reported last month, revenue was C$328 million compared to C$293.5 million in the prior year. 2023 marked the tenth consecutive year of record revenues for Knight.
For comments and feedback contact: editorial@rttnews.com
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.